An analysis of SPRINT trial data may recast disorders of left ventricular (LV) conduction, usually considered something to manage after the fact, as preventable. The study points to hypertension as a ...

Abbott Laboratories (NYSE:ABT) released new late breaking clinical data on its advanced cardiac devices, focusing on pulsed ...

A smart T-shirt with the power of AI could in the future detect heart conditions as people go about their daily lives, thanks to research at Imperial College London. Currently, people with symptoms ...

Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for ...

Widening the pool of patients who receive ambulatory monitoring after TAVI for aortic stenosis may improve early detection of serious arrhythmias irrespective of the setting of new conduction ...

Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...

TCT 354: Contemporary Nationwide Trends in Utilization of Invasive Physiology and Intravascular Imaging During Percutaneous Coronary Intervention Among Older Patients Receive the the latest news, ...

Abbott (NYSE: ABT) today announced new late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PFA) and conduction system pacing (CSP) ...

San Diego, CA - Working with both mouse and human subjects, a team of researchers has identified the underlying molecular pathway that appears to trigger progressive heart failure and sudden death in ...